During the past decade, St. Joseph Krankenhaus Berlin conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Joseph Krankenhaus Berlin" #1 sponsor was "Baxter Healthcare Corporation" with 1 trials, followed by "Celgene" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Hadassah Medical Organization" with 1 trials sponsored and "Pieris Pharmaceuticals GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Joseph Krankenhaus Berlin" #1 collaborator was "European Society of Intensive Care Medicine" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator, "Gambro Dialysatoren GmbH" with 1 trials as a collaborator, "International Sepsis Forum" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "St. Joseph Krankenhaus Berlin" are "Anemia of Chronic Kidney Disease" (1 trials), "Idiopathic Parkinson Disease" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Renal Insufficiency" (1 trials). Many other conditions were trialed in "St. Joseph Krankenhaus Berlin" in a lesser frequency.

Most popular intervention types in "St. Joseph Krankenhaus Berlin" are "Drug" (4 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Avonex" (1 trials), "GamCath Dolphin® Protect central venous catheter" (1 trials), "GamCath® central venous catheter" (1 trials) and "Interferon beta-1a" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Joseph Krankenhaus Berlin" are 6 trials for "All" genders.

Currently, there are NaN active trials in "St. Joseph Krankenhaus Berlin". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in St. Joseph Krankenhaus Berlin, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Joseph Krankenhaus Berlin, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".